Gossamer Bio, Inc. (GOSS)
$9.31-5.77%Close
SELLCRISIS · day 23
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $2.2B
- Beta
- 2.00
- P/E (TTM)
- -0.24
- Short % float
- 0.69%
- Days to cover
- 3.5
- SI change
- +30.5%
- 1W
- -13.07%
- 1M
- -18.26%
- vs SPY 1W
- -14.23%
- vs SPY 1M
- -21.25%
Industry peers
FMP comparable companies · ranked by market cap
- RAPTRAPT Therapeutics, Inc.$1.6B$58.01
- KALVKalVista Pharmaceuticals, Inc.$1.4B$27.00
- VTYXVentyx Biosciences, Inc.$1.0B$14.00
- RIGLBUYRigel Pharmaceuticals, Inc.$888MBULLQ 9$47.99+0.74%
- CRVSSELLCorvus Pharmaceuticals, Inc.$875MCRISISQ 13$10.41+3.04%
- LXRXSELLLexicon Pharmaceuticals, Inc.$782MCRISISQ 5$1.76-4.55%
- OLMASELLOlema Pharmaceuticals, Inc.$694MCRISISQ -1$7.94+0.00%
- FDMTSELL4D Molecular Therapeutics, Inc.$658MCRISISQ 4$12.59+4.96%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
